BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35982578)

  • 1. Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis.
    Zhang X; Misra SK; Moitra P; Zhang X; Jeong SJ; Stitham J; Rodriguez-Velez A; Park A; Yeh YS; Gillanders WE; Fan D; Diwan A; Cho J; Epelman S; Lodhi IJ; Pan D; Razani B
    Autophagy; 2023 Mar; 19(3):886-903. PubMed ID: 35982578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages.
    Zhang H; Ge S; Ni B; He K; Zhu P; Wu X; Shao Y
    Autophagy; 2021 Dec; 17(12):4218-4230. PubMed ID: 33849389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae.
    Emanuel R; Sergin I; Bhattacharya S; Turner J; Epelman S; Settembre C; Diwan A; Ballabio A; Razani B
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1942-1952. PubMed ID: 25060788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis.
    Sergin I; Evans TD; Zhang X; Bhattacharya S; Stokes CJ; Song E; Ali S; Dehestani B; Holloway KB; Micevych PS; Javaheri A; Crowley JR; Ballabio A; Schilling JD; Epelman S; Weihl CC; Diwan A; Fan D; Zayed MA; Razani B
    Nat Commun; 2017 Jun; 8():15750. PubMed ID: 28589926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells.
    Baltazar GC; Guha S; Lu W; Lim J; Boesze-Battaglia K; Laties AM; Tyagi P; Kompella UB; Mitchell CH
    PLoS One; 2012; 7(12):e49635. PubMed ID: 23272048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA Gpr137b-ps Promotes Advanced Atherosclerosis via the Regulation of Autophagy in Macrophages.
    Qu W; Zhou X; Jiang X; Xie X; Xu K; Gu X; Na R; Piao M; Xi X; Sun N; Wang X; Peng X; Xu J; Tian J; Zhang J; Guo J; Zhang M; Zhang Y; Pan Z; Wang K; Yu B; Sun B; Li S; Tian J
    Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):e468-e489. PubMed ID: 37767704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion.
    Xia Y; Liu N; Xie X; Bi G; Ba H; Li L; Zhang J; Deng X; Yao Y; Tang Z; Yin B; Wang J; Jiang K; Li Z; Choi Y; Gong F; Cheng X; O'Shea JJ; Chae JJ; Laurence A; Yang XP
    Autophagy; 2019 Jun; 15(6):960-975. PubMed ID: 30681394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.
    Li W; Sultana N; Siraj N; Ward LJ; Pawlik M; Levy E; Jovinge S; Bengtsson E; Yuan XM
    J Cell Mol Med; 2016 Sep; 20(9):1664-72. PubMed ID: 27079462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.
    Jeong SJ; Stitham J; Evans TD; Zhang X; Rodriguez-Velez A; Yeh YS; Tao J; Takabatake K; Epelman S; Lodhi IJ; Schilling JD; DeBosch BJ; Diwan A; Razani B
    Autophagy; 2021 Nov; 17(11):3740-3752. PubMed ID: 33706671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Shao Q; Yang M; Liang C; Ma L; Zhang W; Jiang Z; Luo J; Lee JK; Liang C; Chen JF
    Autophagy; 2020 Sep; 16(9):1635-1650. PubMed ID: 31847700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradable Nanoparticles Restore Lysosomal pH and Autophagic Flux in Lipotoxic Pancreatic Beta Cells.
    Zeng J; Shirihai OS; Grinstaff MW
    Adv Healthc Mater; 2019 Jun; 8(12):e1801511. PubMed ID: 30698920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.
    Bourdenx M; Daniel J; Genin E; Soria FN; Blanchard-Desce M; Bezard E; Dehay B
    Autophagy; 2016; 12(3):472-83. PubMed ID: 26761717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
    Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
    Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis.
    Evans TD; Jeong SJ; Zhang X; Sergin I; Razani B
    Autophagy; 2018; 14(4):724-726. PubMed ID: 29394113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D
    Chan H; Li Q; Wang X; Liu WY; Hu W; Zeng J; Xie C; Kwong TNY; Ho IHT; Liu X; Chen H; Yu J; Ko H; Chan RCY; Ip M; Gin T; Cheng ASL; Zhang L; Chan MTV; Wong SH; Wu WKK
    Autophagy; 2022 Sep; 18(9):2050-2067. PubMed ID: 34989311
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
    Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
    Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation and beyond: the macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis.
    Sergin I; Evans TD; Razani B
    Curr Opin Lipidol; 2015 Oct; 26(5):394-404. PubMed ID: 26241101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.